{
    "nctId": "NCT02207335",
    "briefTitle": "Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer",
    "officialTitle": "A Multicenter Randomized Phase \u2162 Clinical Trial of Gemcitabine in Combination With Capecitabine Versus Gemcitabine Plus Carboplatin as First-line Treatment in Triple-negative Recurrent or Metastatic Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "RECIST 1.1",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* 18-70 years old\n* ECOG 0-1\n* Expected lifetime more than 12 weeks\n\nExclusion Criteria:\n\n* Pregnancy\n* Brain Metastasis,\n* Severe Infection",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}